drugset / Trial / NCT02336503
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the safety and efficacy of 3 doses of BBI-4000 and vehicle (4 treatment arms), when applied once a day for 4 weeks, for the treatment of axillary hyperhidrosis.
Timeline
- Start
- 2015-03-10
- Primary completion
- 2015-11-05
- Completion
- 2015-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SOFPIRONIUM | Small molecule | 5 % | Topical |
| Subject | SOFPIRONIUM | Small molecule | 10 % | Topical |
| Subject | SOFPIRONIUM | Small molecule | 15 % | Topical |